Newly Published Epilepsia Supplement Highlights Potential of Third Generation Antiseizure Medications to Help More Patients Achieve Seizure Freedom
Hand-out
Press Releases
March 20, 2025

Newly Published Epilepsia Supplement Highlights Potential of Third Generation Antiseizure Medications to Help More Patients Achieve Seizure Freedom

PARAMUS, N.J., March 20, 2025 /PRNewswire/ -- SK Life Science, Inc., a U.S. pharmaceutical company developing treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co.,

bradford

The Bradford Era

More by this Author
Local & Social